OBJECTIVES: To evaluate the effect on breast cancer mortality during the first 10 years of the mammography service screening programme that was introduced in Copenhagen in 1991. DESIGN: Cohort study. SETTING: The mammography service screening programme in Copenhagen, Denmark. PARTICIPANTS: All women ever invited to mammography screening in the first 10 years of the programme. Historical, national, and historical national control groups were used. MAIN OUTCOME MEASURES: The main outcome measure was breast cancer mortality. We compared breast cancer mortality in the study group with rates in the control groups, adjusting for age, time period, and region. RESULTS: Breast cancer mortality in the screening period was reduced by 25% (relative risk 0.75, 95% confidence interval 0.63 to 0.89) compared with what we would expect in the absence of screening. For women actually participating in screening, breast cancer mortality was reduced by 37%. CONCLUSIONS: In the Copenhagen programme, breast cancer mortality was reduced without severe negative side effects for the participants.
OBJECTIVES: To evaluate the effect on breast cancer mortality during the first 10 years of the mammography service screening programme that was introduced in Copenhagen in 1991. DESIGN: Cohort study. SETTING: The mammography service screening programme in Copenhagen, Denmark. PARTICIPANTS: All women ever invited to mammography screening in the first 10 years of the programme. Historical, national, and historical national control groups were used. MAIN OUTCOME MEASURES: The main outcome measure was breast cancer mortality. We compared breast cancer mortality in the study group with rates in the control groups, adjusting for age, time period, and region. RESULTS:Breast cancer mortality in the screening period was reduced by 25% (relative risk 0.75, 95% confidence interval 0.63 to 0.89) compared with what we would expect in the absence of screening. For women actually participating in screening, breast cancer mortality was reduced by 37%. CONCLUSIONS: In the Copenhagen programme, breast cancer mortality was reduced without severe negative side effects for the participants.
Authors: Suzie J Otto; Jacques Fracheboud; Caspar W N Looman; Mireille J M Broeders; Rob Boer; Jan H C L Hendriks; André L M Verbeek; Harry J de Koning Journal: Lancet Date: 2003-04-26 Impact factor: 79.321
Authors: Lennarth Nyström; Ingvar Andersson; Nils Bjurstam; Jan Frisell; Bo Nordenskjöld; Lars Erik Rutqvist Journal: Lancet Date: 2002-03-16 Impact factor: 79.321
Authors: F E Alexander; T J Anderson; H K Brown; A P Forrest; W Hepburn; A E Kirkpatrick; B B Muir; R J Prescott; A Smith Journal: Lancet Date: 1999-06-05 Impact factor: 79.321
Authors: Sisse Helle Njor; Anne Helene Olsen; Torben Bellstrøm; Uffe Dyreborg; Martin Bak; Christen Axelsson; Hans Peder Graversen; Walter Schwartz; Elsebeth Lynge Journal: APMIS Suppl Date: 2003
Authors: Stephen W Duffy; Laszlo Tabár; Hsiu-Hsi Chen; Marit Holmqvist; Ming-Fang Yen; Shahim Abdsalah; Birgitta Epstein; Ewa Frodis; Eva Ljungberg; Christina Hedborg-Melander; Ann Sundbom; Maria Tholin; Mika Wiege; Anders Akerlund; Hui-Min Wu; Tao-Shin Tung; Yueh-Hsia Chiu; Chen-Pu Chiu; Chih-Chung Huang; Robert A Smith; Måns Rosén; Magnus Stenbeck; Lars Holmberg Journal: Cancer Date: 2002-08-01 Impact factor: 6.860
Authors: Gregory Boverman; Tzu-Jen Kao; Rujuta Kulkarni; Bong Seok Kim; David Isaacson; Gary J Saulnier; Jonathan C Newell Journal: IEEE Trans Med Imaging Date: 2008-10 Impact factor: 10.048